Search
Memorial Sloan Kettering Cancer Center feted three gifted young investigators for their insightful contributions to cancer research in a public symposium on December 1, 2011.
Learn about MSK's new Program for Drug Development in Leukemia (PDD-L), which will offer more clinical trials for many types of leukemia.
Radiation therapy after surgery can sharply reduce the chance that certain low-risk breast cancers will return.
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
Learn from gynecologic surgeon Vance Broach about cervical cancer prevention, diagnosis, and treatment.
Treating pituitary tumors with combination immunotherapy may be an effective treatment strategy, especially for tumors that are resistant to temozolomide.